Infection test kit AccuPower®
hepatitis CHCVclinical

infection test kit
infection test kit
Add to favorites
Compare this product
 

Characteristics

Applications
infection, hepatitis C
Micro-organism
HCV
Sample type
clinical, serum, plasma, laboratory
Analysis mode
real-time, for real-time PCR

Description

AccuPower® HCV Quantitative RT-PCR Kit is an in vitro diagnostic kit designed for the quantification of hepatitis C virus (HCV) RNA in human samples such as serum and EDTA-plasma through real-time PCR. Product Description Hepatitis C is a liver disease caused by hepatitis C virus (HCV). HCV infection is generally asymptomatic during the acute phase and about 85% of them become chronically infected. However, most instances of acute infection are clinically undetectable. In rare cases, acute hepatitis is accompanied by jaundice, malaise, weakness and anorexia. Since HCV cannot be grown in the clinical laboratory, more sensitive molecular testing is needed to confirm the presence of the virus such as quantitative real-time PCR. Features and Benefits HCV Genotype Detection: HCV genotype 1, 2, 3, 4, 5 and 6 are detectable with high sensitivity. Signature Convenience: One-step RT-PCR premix type. All components for the assay are contained within a tube. Enhanced Sensitivity & Specificity: Bioneer’s proprietary Dual HotStart technology accomplishes high sensitivity and specificity. Remarkable Stability: Vacuum-dried premix allows stable and reproducible results. High Quality: All diagnostic kits manufactured by Bioneer are under strict quality control guidelines. Specifications Kit Contents - PCR Premix, SPC 1~5, LPC, HPC, NTC, SL buffer, DEPC D.W. Instrumentation - ExiStation™ Universal Molecular Diagnostic System Tests - 96

Other Bioneer Corporation products

PCR & RT-PCR

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.